PromptCare selected as In-Network Pharmacy for Qfitlia™ (fitusiran) to Treat Patients 12 Older with Hemophilia A and B
PromptCare’s Hemophilia Expertise Leads to Access to New Treatment Option for Patients NEW PROVIDENCE, NJ, NJ, UNITED
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
PromptCare’s Hemophilia Expertise Leads to Access to New Treatment Option for Patients
NEW PROVIDENCE, NJ, NJ, UNITED STATES, October 23, 2026 /EINPresswire.com/ — PromptCare, a leading provider of specialty pharmacy and infusion services, announced today the selection by Sanofi as an in-network specialty pharmacy for Qfitlia™ (fitusiran), a unique treatment for patients with hemophilia A or B. The addition expands PromptCare’s already comprehensive bleeding disorders offering and gives patients and prescribers another option backed by a team that has served the bleeding disorder community for decades.
Qfitlia™ is an FDA-approved treatment designed to reduce bleeding episodes in patients ages 12 and older with hemophilia A or B, with or without Factor VIII or IX inhibitors. PromptCare’s inclusion in the Qfitlia™ specialty pharmacy network expands access to this important therapy through a provider with decades of experience caring for patients with bleeding disorders.
“Being selected by Sanofi as an in-network specialty pharmacy for Qfitlia™ reflects the trust we’ve earned through decades of dedicated service to the bleeding disorders community, as well as our capabilities in comprehensive specialty care for highly complex and chronic conditions,” says Jacob Cooper, President of PromptCare’s Specialty Pharmacy and Infusion Division. “Our team understands the complexities of managing hemophilia patients and the importance of connecting them with innovative treatment options. We’re proud to build on our longstanding expertise and help bring this therapy to patients.”
This selection further strengthens PromptCare’s comprehensive bleeding disorders program and differentiated offering for limited distribution networks and reinforces its commitment to advancing patient access, supporting treatment adherence, and delivering exceptional care.
For more information about receiving Qfitlia™ therapy and support through PromptCare, call 866-451-8804.
###
About PromptCare
PromptCare is a leading national provider of specialty infusion, respiratory, and pharmaceutical therapies, helping adult and pediatric patients with complex, chronic, and rare conditions live their fullest life. To learn more, visit promptcare.com.
Holly Rohleder
PromptCare, Inc.
+1 913-626-9707
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
